Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Considering Robotic Surgery For Breast Cancer? Proceed With Caution, FDA Says

Executive Summary

Though the FDA has approved robotic assisted surgery for many procedures, the US agency cautions that safety and efficacy of the technology has not been well-established for cancer-related surgeries, particularly mastectomies.

You may also be interested in...

Citizen Petition Raises Concerns About Robotic Mastectomy Trial

One doctor is using his expertise to advocate for better premarket surveillance of cancer-treatment devices.

Robots Are The Future – And The Future Is Now

Robotic assisted surgery (RAS) has opened a new frontier of surgery, giving surgeons the ability to peer deeper into the human anatomy and reach areas of the body with a degree of precision beyond human capability.

Robots Reduce Complications For Men Having Radical Prostate Surgery, Study Finds

A Taiwanese study found that men undergoing robot-assisted surgery for prostate cancer had better outcomes than those receiving traditional procedures.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts